- Joined
- Nov 23, 2012
- Messages
- 692
- Reaction score
- 322
Will there be a resurgence of PP Anesthesia with these AMCs struggling?
Mednax: Iffy Business Model, And Q1 2017 - Mednax, Inc. (NYSE:MD) | Seeking Alpha
Mednax: Iffy Business Model, And Q1 2017
Jun. 5.17 | About: Mednax, Inc. (MD)
Summary
MEDNAX is built upon a consolidation model, one that has not seen any operating leverage generated over the past four years.
Q1 2017 results proved that the business is, however, susceptible to significant margin contraction when trends move against the company.
The company has a weak reputation with its own staff and independent doctors, mostly due to lower-than-average pay - likely done to keep up margins.
If trends continue, there is 15-20% downside to shares from current levels, with further weakness possible.
Mednax: Iffy Business Model, And Q1 2017 - Mednax, Inc. (NYSE:MD) | Seeking Alpha
Mednax: Iffy Business Model, And Q1 2017
Jun. 5.17 | About: Mednax, Inc. (MD)
Summary
MEDNAX is built upon a consolidation model, one that has not seen any operating leverage generated over the past four years.
Q1 2017 results proved that the business is, however, susceptible to significant margin contraction when trends move against the company.
The company has a weak reputation with its own staff and independent doctors, mostly due to lower-than-average pay - likely done to keep up margins.
If trends continue, there is 15-20% downside to shares from current levels, with further weakness possible.